Nuclear Medicine Market Worth USD 15.8 Million by 2025 | CAGR of 10.1%

The MarketWatch News Department was not involved in the creation of this content.

Dec 03, 2020 (Heraldkeepers) —
The latest report pertaining to ‘Nuclear Medicine Market’ provides a detailed analysis regarding market size, revenue estimations and growth rate of the industry. In addition, the report illustrates the major obstacles and newest growth strategies adopted by leading manufacturers who are a part of the competitive landscape of this market.

Nuclear Medicine Market is valued at USD 8.12 Million in 2018 and expected to reach USD 15.8 Million by 2025 with CAGR of 10.1% over the forecast period.

Get Sample Copy of This Premium Report https://brandessenceresearch.com/requestSample/PostId/406

**The sample pages of this report is immediately accessible on-demand.**

Top Nuclear Medicine Companies

Nuclear Medicine Market Report covers prominent players are like,

  • Bracco Imaging S.P.A.
  • Cambridge Isotope Laboratories, Inc
  • Cardinal Health, Inc.
  • Covidien, Plc
  • Eczacibasi-Monrol
  • Fujifilm Holdings Corporation
  • GE Healthcare (Subsidiary Of General Electric Company)
  • IBA Group
  • Isotec, Ntp Radioisotopes (Pty), Ltd
  • Siemens Healthcare (Subsidiary Of Siemens AG)
  • Taiyo Nippon Sanso Corporation
  • Urenco Limited
  • Rotem Industries, Ltd., Inc.

Nuclear Medicine Market report is segmented on the basis of type, procedural volumes, application, end-user and regional & country level. Based upon type, nuclear medicine market is classified as diagnostic nuclear medicine, therapeutic nuclear medicine, research nuclear medicine and other. Based upon procedural volumes, nuclear medicine market is classified into diagnostic procedures, therapeutic procedures and other. Based upon application, nuclear medicine market is classified into oncology, cardiology, neurology, thyroid, lymphoma, endocrinology and other. Based upon end-user, nuclear medicine market is classified into diagnostic centers, hospitals, research centers and other.

Market Analysis of Nuclear Medicine-

Nuclear medicine is involving the application of radioactive substances in the diagnosis and treatment of various diseases. Nuclear Medicine images can support the physician in diagnosing of many diseases and conditions such as analyze kidney and spleen function, image blood flow and function of the heart and scan the lungs for respiratory and blood-flow problems. Nuclear medicine uses radioactive materials helps to diagnose and treat a wide variety of diseases and disorders. It provides unique information about the human body and health. Nowadays nuclear medicine is expected to be the most sensitive approach to measure in vivo physiology, biochemistry and metabolism. The future development of nuclear medicine depends on an infrastructure of physics, mathematics and chemical biology.

The regions covered in this Global Nuclear Medicine market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Nuclear Medicine is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Global Nuclear Medicine market Report covers prominent players are like Bracco Imaging S.P.A., Cambridge Isotope Laboratories, Inc., Cardinal Health, Inc., Covidien, Plc, Eczacibasi-Monrol, Fujifilm Holdings Corporation, GE Healthcare (Subsidiary Of General Electric Company), IBA Group, Isotec, Ntp Radioisotopes (Pty), Ltd., Siemens Healthcare (Subsidiary Of Siemens AG), Taiyo Nippon Sanso Corporation, Urenco Limited, Rotem Industries, Ltd., Inc. and others.

Increasing prevalence of anxiety and diagnosis of various

Read more

Global fitness app market size valuation to reach USD 15.96 billion by 2026

Selbyville, Delaware, Nov. 24, 2020 (GLOBE NEWSWIRE) — As per reliable estimates, worldwide fitness app market size is predicted to reach USD 15.96 billion mark by 2026. Rising concerns associated with unhealthy habits, evolving consumer lifestyle, and growing obese population are some of the key factors propelling the market expansion.

The study elaborates on several market segmentations including app type, device type, OS platform type, and regional outlook. Additionally, the document conducts a thorough SWOT analysis of various companies operating in this business sphere.

The research report also analyzes the impact of COVID-19 outbreak on industry expansion graph and valuation in the ensuing years, further allowing for advanced decision-making during investment assessment.

Request Sample copy of this Report @https://www.marketstudyreport.com/request-a-sample/1695317/

The surge in obese population coupled with rising adoption of sedentary lifestyle have resulted in increased pervasiveness of diseases such as hypertension and diabetes. In addition to this, rising per capita income along with increasing awareness pertaining to health and nutrition are stimulating the overall industry outlook.

According to industry analysts, the number of gym and health club memberships has significantly increased in the recent past. Additionally, rising smartphone penetration, widespread adoption of mobile devices, and easy accessibility to high-speed internet are positively impacting the remuneration scale of global fitness app market.

Availability of numerous types of fitness apps such as Sweat: Kayla Itsines Fitness and Runstatic coupled with high concentration of companies are also facilitating the business scenario. In 2015 for instance, Adidas acquired the Austrian company Runstatic in order to improve its overall market share. Thus, focus among major companies towards expanding their product portfolio through innovative launches and strategic collaborations are aiding the expansion of global fitness app market.

Highlighting the regional outlook

Global fitness app industry is bifurcated into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. According to authentic estimations, North America is expected to capture majority market share by the year 2026.

Growing population and surging disposable income are favoring the regional market outlook. Moreover, widespread adoption of sedentary lifestyle and rising health concerns have augmented the demand for fitness apps, which in turn is positively swaying the business dynamics in North America.

Meanwhile, Asia-Pacific fitness app market is set to record the highest CAGR through 2026. Factors such as growing purchasing power, rising health cognizance, high concentration of fitness centers, and increasing smartphone penetration have allowed Asia-Pacific to emerge as a major revenue generator for worldwide fitness app market.

To access a sample copy or view this report in detail along with the table of contents, please click the link below:

https://www.marketstudyreport.com/reports/fitness-app-market-share-size-trends-industry-analysis-report-by-app-type-fitness-and-activity-tracking-diet-and-nutrition-by-device-type-smartphones-tablets-wearable-devices-by-gender-by-os-platform-by-region-segment-forecast-2018-2026

Global Fitness App Market by App Type (Revenue, USD Billion, 2015-2026)

  • Medication Adherence
  • Lifestyle Management
  • Nutrition & Diet
  • Disease Management
  • Workout & Exercise Apps

Global Fitness App Market by Device Terrain (Revenue, USD Billion, 2015-2026)

  • Wearable Devices
  • Tablets
  • Smartphones

Global Fitness App Market by OS Platform (Revenue, USD Billion, 2015-2026)

Global Fitness App Market Regional Outlook (Revenue, USD Billion, 2015-2026)

North America

Europe

  • Netherlands
  • Russia
  • Belgium
  • Spain
Read more

Online Fitness Market Size to Reach USD 59,231 Billion by 2027 | CAGR of 33.1%

BANGALORE, India, Oct. 29, 2020 /PRNewswire/ — Online/Virtual Fitness Market by Streaming Type (Live, and On-demand), Device Type (Smart TV, Smartphones, Laptops Desktops & Tablets, and Others), Session Type (Group and Solo), Revenue Model (Subscription, Advertisement, and Hybrid) and End User (Professional Gyms, Sports Institutes, Defense Institutes, Educational Institutions, Corporate Institutions, Individuals, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2027 – Published on Valuates Reports in Beauty & Fitness Category.

Valuates Reports Logo

The global Online fitness market size was valued at USD 6,046 Million in 2019 and is projected to reach USD 59,231 Million by 2027, growing at a CAGR of 33.1% from 2020 to 2027.

North America is expected to hold the largest Online Fitness Market share during the forecast period. The major factor driving the growth of North America’s market share is the increased emphasis on precision medicine and personalized treatment and the significant presence of numerous health and wellness organizations across this region.

Major factors driving the growth of online fitness market size are the need for specialized fitness sessions to achieve physical fitness, the interest of health insurance companies in online fitness services to minimize the cost of health insurance, increasing demand for fitness based on AR or VR, growing demand for healthy food.

Furthermore, recent COVID-19 has had a positive effect on the online fitness market size. The COVID-19 pandemic has disrupted people’s lives and forced fitness centers to remain closed. This scenario has, in turn, led to the rapid adoption of virtual fitness solutions as individuals have begun workouts at their homes.

Request a Sample Copy of the Report For COVID-19 Impact Analysis on Online Fitness Market: https://reports.valuates.com/request/sample/ALLI-Manu-0V29/online_fitness_industry

TRENDS INFLUENCING THE ONLINE FITNESS MARKET SIZE

The increase in digitalization will propel the expansion of the online fitness market size along with the trend of connected fitness equipment that allows users to monitor health parameters, such as pulse rate and calories. Several businesses are launching virtual classes that allow users to incorporate fitness experiences with their smart devices.

The rising penetration of smart devices and the internet is expected to increase the growth of the online fitness market size. The penetration of smartphones and tablets has resulted in high fitness app adoption across all demographics. Some apps provide personalized services based on specifications and body physiology.

Corporate institutions that incorporate gyms into their infrastructure would boost the demand for the online fitness industry. Several fitness clubs partner with businesses to facilitate the introduction of gyms to improve employee productivity in the work environment.

Awareness about the growing health issues due to sedentary lifestyles is fueling the online fitness market size. Increasing rates of obesity and associated disorders, including heart attacks and diabetes, enable individuals to take individual fitness lessons to cope with specific health problems.

However, interruptions in the class flow due to tech glitches, along with the lack of real contact with the teacher, may, to some degree, impede the growth of the online fitness industry.

View market snapshot before purchasing

ONLINE FITNESS

Read more

Global Herbal medicine market size to exceed USD 411 billion by 2026

The latest report on ‘herbal medicine market’ thoroughly scrutinizes this business space while providing qualitative insights, historical data, and verifiable projections for 2020-2026 to the companies that are operational in this industry.

Selbyville, Delaware, Oct. 29, 2020 (GLOBE NEWSWIRE) — According to the credible sources, global herbal medicine market is expected to reach a valuation of USD 411.2 billion by the year 2026. Increasing product adoption by the population across the world, rising support & funding from government for research & development of herbal medicines, and easy availability of the product are the major factors propelling the industry growth. Further, benefits such as low cost, and no side effects are also contributing to herbal medicine market outlook.

Global herbal medicine market report studies the landscape based on several segmentations, such as source type, distribution channel, category, form, and regional outlook. It enlists the factors that influence the segmental share along with their growth rate projections over the analysis timeframe. Furthermore, the document contains granular information about competitive landscape of the market defined by each participant, along with their business profile, product portfolio, and market stake.

Highlighting category

Estimates cites that herbal pharmaceuticals segment held a major share in global herbal medicine industry in 2019, owing to rising geriatric population, and high consumer awareness. Other factors like negligible side effects, supplier innovations, and launch of Current Good Manufacturing Practices (CGMP) by the FDA for dietary supplements are expected to drive the segmental growth.

Meanwhile, herbal beauty products segment is predicted to register robust growth rate during the forecast period, mainly due to increase in sales of beauty products. High disposable income, and availability of large product portfolio are stimulating the overall market remuneration.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2963796/

Elaborating form outlook

Global herbal medicine market, as per form type, is segmented into powders, tablets & capsules, syrups, extracts, and others. Among these, extract segment is expected to witness high gains during the forecast period, owing to its utilization in manufacturing several products. Herbs & plants extracts vary from alcoholic extracts, hot water extracts to long-term boiled extracts, and acetic acid extracts depending on the solvent.

Considering source type

As per the report, whole plant sourced herbal medicine market segment is gaining substantial traction due to product’s ability to cure various diseases. As per National Center for Biotechnology Information, about 70% to 80% of the population worldwide preferred traditional drugs for treatment.

Notably, traditional medications are extracted from roots & barks, leaves, fruits, flowers, stalk, and cloves of the plant. For instance, chamomile, a flower, is used as sedative and anxiolytic for relaxation and anxiety. It also reduces swelling and inflammation while aiding in wound healing.  

Analyzing distribution channel

Worldwide herbal medicine market share from e-commerce segment is projected to grow momentously during the forecast period, owing to rising awareness regarding traditional medication, high penetration of mobile phones with internet facilities, and easy accessibility in small towns & villages. Further, rising geriatric population, and cost efficiency of

Read more

Hair Transplant Market revenue to cross USD 40 Bn by 2026: Global Market Insights, Inc.

Some of the major hair transplant market players include Allergan Plc, Bernstein Medical, Bosley, GETFUE Hair Clinics Ltd., Hair Restoration BlackRockHRBR, Hair Club, Venus Concept (NeoGraft), Hairline International Hair and Skin Clinic, Hair Transplant Centre Turkey, Hair Transplants of Florida, Cole Instruments Inc. among others.

Selbyville, Delaware, Oct. 26, 2020 (GLOBE NEWSWIRE) —

According to latest report “Hair Transplant Market by Method (Follicular Unit Extraction [FUE], Follicular Unit Transplantation [FUT]), Product (Gel, Serum, Drugs, Multivitamins), Therapy (Platelet Rich Plasma, Stem Cell Therapy, Laser Therapy), Gender (Male, Female), Service Provider (Hospitals, Clinics, Surgical Centers), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2026”, by Global Market Insights, Inc., the market valuation of hair transplant will cross $40.1 billion by 2026.

Rise in number of people suffering from hair loss in Middle East and Africa region will act as a high impact rendering factor for the market growth. Increase in number of people suffering from hair loss in the Middle Eastern countries has resulted in more young men opting for hair transplant procedures. The major factors contributing to male pattern baldness are stress, genetics, illness or medication, climatic and water condition along with physiological factors such as malnutrition and ageing. According to the recently published article, around 60% of the male population in Middle East region is expected to experience hair loss in their lifetime, as compared to global average of 40%.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2810

Recent technological advancements, automation and cost-effectiveness of hair transplant procedure will drive the market value. Rising demand for single session hair restoration surgeries coupled with increase in awareness regarding physical appearance will further propel the market revenue.

Follicular unit extraction (FUE) segment in the hair transplant market valued more than USD 3,270 million in 2019 impelled by the rising number of men suffering from pattern baldness and growing adoption of the technologically advanced hair transplant methods by the surgeons. Furthermore, growing prevalence of alopecia cases coupled with increase in aging population base across the globe will fuel the segment growth in the coming years.

The hair transplant market for drugs segment is predicted to witness 25.5% growth rate from 2020 to 2026. The enhancement in alopecia treatment is mainly driven by the growing demand for hair loss treatment drugs that have shown higher effectiveness along with minimal side effects. In addition, increasing investment made by the leading players to develop novel hair transplant drugs will further boost the market expansion.

Platelet rich plasma (PRP) therapy in the hair transplant market accounted for USD 358 million in 2019. PRP is considered as one of the innovative and technological advanced hair transplant therapies for the patients suffering from hair thinning. PRP contains more than 20 growth factors that are considered exceptional for hair regrowth by stimulating the new hair cells and hence, this procedure will showcase higher adoption than other therapies.

Hair transplant market from male patient segment is estimated to expand at 25.8% CAGR through 2026 owing

Read more

Dravet Syndrome Treatment Market | Market to Grow by Over USD 396 Million During 2020-2024

The Dravet syndrome treatment market is set to grow by USD 396.15 million accelerating at a CAGR of over 9%, during the period spanning over 2020-2024. One of the key factors driving growth is the rising strategic alliances. Several pharmaceutical companies are working together to develop drugs for the treatment of Dravet syndrome. Increasing new product launches is a significant trend that will further stimulate market growth. Increasing product launches are making the market more competitive and increasing the availability of drugs for patients.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201022005201/en/

Technavio has announced its latest market research report titled Global Dravet Syndrome Treatment Market 2020-2024 (Graphic: Business Wire)

To learn more about the global trends impacting the future of market research, download a free sample now

Parent Market Analysis

Technavio categorizes the Dravet syndrome treatment market as a part of the pharmaceutical market within the overall healthcare industry. The parent, pharmaceuticals market covers products and companies engaged in R&D or production of generic drugs, non-generic drugs, and veterinary drugs.

Growth in the healthcare market will be driven by factors such as increasing life expectancy, improving access to better healthcare in emerging economies, rising prevalence of sedentary lifestyle, rising cases of chronic conditions, and rising number of partnerships between pharmaceutical companies.

Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts

Dravet Syndrome Treatment Market: Segmentation by Geography

The report segments the market by Geography: North America, Europe, Asia, and ROW. 44% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for Dravet syndrome treatment in North America.

Dravet Syndrome Treatment Market: Segmentation by Product

The SGDs segment was leading the market in 2019. This report provides an accurate prediction of the contribution of all the segments to the growth of the Dravet syndrome treatment market size.

Dravet Syndrome Treatment Market: Growth Drivers

The market is driven by the rising number of strategic alliances among vendors. Many vendors in the market are partnering with other vendors to develop effective drugs for the treatment of Dravet syndrome. For instance, in September 2018, Supernus Pharmaceuticals Inc. announced its plans to acquire Biscayne Neurotherapeutics (Biscayne), a privately-held company developing a novel treatment for epilepsy. Similarly, in August 2020, Takeda and Ovid completed the Phase II trials of the Dravet syndrome drug and are planning for the Phase III registrational trials. Such developments are expected to boost market growth during the forecast period.

Dravet Syndrome Treatment Market: Challenges to Overcome

Many patients who do not respond to medications are looking for alternative treatment methods to treat Dravet syndrome. Some of the alternative treatment options such as herbs, vitamins, biofeedback, acupuncture, VNS, and keto diet are gaining popularity, which is affecting the growth of market vendors.

Dravet Syndrome Treatment Market: Vendor landscape

This report provides information on

Read more

The global clinical microbiology market size is projected to reach USD 5.3 billion by 2025 from USD 3.9 billion in 2020, at a CAGR of 6.5%

Factors such as the technological advancements in the market are propelling the growth of the clinical microbiology market. Additionally, rising inclination epidemics like COVID-19 and investments from private and public sectors affect the growth of clinical microbiology market.

New York, Oct. 21, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Clinical Microbiology Market by Application, Disease, Product, End User – Global Forecast to 2025” – https://www.reportlinker.com/p03887589/?utm_source=GNW
However, unfavorable reimbursement scenarios in some countries is hampering the growth of this market.

The recent COVID-19 global pandemic has also impacted the clinical microbiology market.Demand from the main end-users has declined as key regions, and countries have imposed social distancing rules and lockdowns.

This impact is expected to be short-term, and no adverse effects are to be foreseen after the market gradually reopens.

The reagent segment to witness the highest growth rate in the clinical microbiology market, by product, during the forecast period.
The reagent segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the high prevalence of infectious diseases across major markets (resulting in a growing number of clinical diagnostic procedures), the increasing trend of reagent rental agreements along with instrument sales, and a rising number of life science researches in the field of specific reagents for targeted infectious disease diagnosis and treatment, especially across emerging countries.

The respiratory diseases accounted for the largest share of the clinical microbiology market, by diseases, in 2019.
The respiratory diseases segment accounted for the largest share of the clinical microbiology market in 2019.This segment is also estimated to register the highest CAGR during the forecast period.

The large share and high growth rate of this segment can be attributed to factors such as the large patient population suffering from respiratory diseases, rising prevalence of target respiratory diseases (such as TB, asthma, COPD, and bronchitis) across developing countries, and growth in the number of epidemic outbreaks of respiratory infections.

The hospitals & diagnostics centers segment accounted for the largest share of the clinical microbiology, by end-users, in 2019
The hospitals and diagnostic centers segment accounted for the largest market share in 2019. The large share of this segment is attributed to the high incidence of target diseases (such as tuberculosis, HIV-AIDS, malaria, and epidemic diseases), availability of technologically advanced products (such as molecular diagnostic products and PCR and NGS-based instruments) for infectious disease diagnosis, growing awareness among doctors and clinicians regarding the advantages offered by molecular diagnostic products for fast and effective disease diagnosis, and ongoing expansion of healthcare infrastructure across emerging countries.

The Asia Pacific market to grow at the highest CAGR during the forecast period.
The clinical microbiology market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Government efforts to increase awareness related to genome-based infectious disease diagnosis, supportive regulations for the development and commercialization of advanced clinical microbiology products, rising healthcare expenditure, an increasing number of hospitals and

Read more

The global home healthcare market size is projected to reach USD 274.7 billion by 2025 from USD 181.9 billion in 2020, at a CAGR of 8.6%

during the forecast period. The market growth is mainly driven by factors such as the rapid growth in the elderly population and the rising incidence of chronic diseases, growing need for cost-effective healthcare delivery due to the increasing healthcare costs, and technological advancements in-home care devices.

New York, Oct. 21, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Home Healthcare Market by Product, Service, Indication, Region – Global Forecast to 2025” – https://www.reportlinker.com/p05208355/?utm_source=GNW
On the other hand, changing reimbursement policies, limited insurance coverage, and concerns regarding patient safety are factors limiting the growth of the market to a certain extent. The growing popularity of telehealth and untapped developing regions present significant growth opportunities for players in the home healthcare market.

The cancer segment is expected to dominate the market during the forecast period.
Based on indication, the global home healthcare market is segmented into cancer, respiratory diseases, mobility disorders, cardiovascular diseases & hypertension, pregnancy, wound care, diabetes, hearing disorders, and other indications.The cancer segment accounted for the largest share of the home healthcare market in 2019.

The large share of this segment can primarily be attributed to the high prevalence of cancer cases across the globe and the transforming healthcare system, which allows the management of cancer at home.

Testing, screening & monitoring segment will witness the highest growth in the home healthcare products market.
Based on products, the home healthcare market is segmented into testing, screening, and monitoring products; therapeutic products; and mobility care products.The testing, screening, and monitoring products are expected to witness the highest CAGR during the forecast period.

The high growth of this segment can primarily be attributed to factors such as the rising emphasis on preventive medicine and an increasing number of patients with chronic diseases. The potential to reduce healthcare complications and ensure the portability of devices with high accuracy is also expected to create a significant demand for monitoring and testing devices in the coming year.

North America will dominate the market during the forecast period.
Geographically, the home healthcare market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World.In 2019, North America accounted for the largest share of the home healthcare market.

The large share of this region in the global market is attributed to the rising prevalence of chronic conditions, high healthcare expenditure, high disposable income, the increasing overall geriatric population, high disposable income, and the presence of superior healthcare infrastructure.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type – Tier 1: 36%, Tier 2: 45%, and Tier 3: 19%
• By Designation – C-level: 33%, D-level: 40%, and Others: 27%
• By Region – North America: 36%, Europe: 28%, Asia Pacific: 19%, and Rest of the World: 17%

List of Companies Profiled in the Report
• Fresenius SE & Co. KGaA (Germany)
• GE Healthcare (US)
• Linde plc (Ireland)
• F. Hoffmann-La Roche Ltd (Switzerland)
• A&D Company (Japan)
• BAYADA Home

Read more

From the pandemic declaration to the fall surge, here’s a timeline of Covid-19 in the USd

Experts say the fall Covid-19 surge is here. Infections and hospitalizations are rising across the country. And one leading health official says daily Covid-19 deaths could soon begin climbing, too.



a man wearing a costume: Medics transfer a patient on a stretcher from an ambulance outside of Emergency at Coral Gables Hospital where Coronavirus patients are treated in Coral Gables near Miami, on July 30, 2020. (Photo by Chandan Khanna/AFP/Getty Images)


© Chandan Khanna/AFP/Getty Images
Medics transfer a patient on a stretcher from an ambulance outside of Emergency at Coral Gables Hospital where Coronavirus patients are treated in Coral Gables near Miami, on July 30, 2020. (Photo by Chandan Khanna/AFP/Getty Images)

The alarming trends come ahead of a season that will likely be especially challenging. Students across the country have returned to class and college students — some of whom live in campuses that reported Covid-19 outbreaks — will soon return to visit their families and could unknowingly bring the virus back with them. And Covid-19 will also be stacked up against the flu season and could create what doctors call a “twin-demic.”

Loading...

Load Error

What happens next is unclear. But here’s how we got here:

On April 10, about a month after Covid-19 was declared a pandemic by the World Health Organization, the US hit its first high point during the pandemic, peaking at an average of a little more than 31,800 daily cases, according to data from Johns Hopkins University.

The country also eclipsed more than half a million Covid-19 infections.

Cases were clustered mostly in New York, with other, smaller outbreaks in places such as Washington state, Louisiana and Illinois. Around that time, New York state had more infections than any other country in the world, with more than 160,000 cases. As of October 16, the state has reported more than 481,000 infections.

By June 9, the US had flattened the curve and was averaging about 20,340 new cases daily, Johns Hopkins data showed. States were opening back up after weekslong lockdowns that were put in place to help curb the spread of the virus.

With the easing of measures, more Americans began to venture outside and images and videos emerged of parties and other gatherings with no social distancing and few masks in sight.

By July 22, the nation reached its highest peak of the pandemic, to date, averaging more than 67,000 cases daily. The US was seeing huge spikes in cases in the West and South.

The case surges came weeks after crowds celebrated the July 4 holiday. Across the country, local officials warned more young people were testing positive and helping drive the increase in infections.

Arizona, Florida, California, Texas and Georgia were adding thousands of cases per day. Experts called Florida the epicenter of the pandemic and by the end of the month, more than four dozen hospitals across the state were reporting full ICUs.

By September 12, the summer peak had slipped down to a little more than 34,300 average new cases daily, according to data from Johns Hopkins. That baseline was higher than what it was in the spring and experts warned Americans should work to lower it as the nation was heading into the colder fall and winter months.

Now

Read more